You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥控股(01099.HK)擬成立合資以投建國家醫療醫藥應急保障體系互聯網平台公司
格隆匯 07-06 20:53

格隆匯 7 月 6日丨國藥控股(01099.HK)公佈,於2020年7月6日,公司與中國生物、廣東環球、現代製藥、醫工總院訂立有關擬成立合資公司的合資協議。根據合資協議,公司同意以現金出資人民幣6000萬元,佔合資公司總出資額的60%,中國生物、廣東環球、現代製藥及醫工總院同意各自以現金出資人民幣1000萬元,各佔合資公司總出資額的10%。

合資公司成立後,將投資建設一家國家醫療醫藥應急保障體系互聯網平台公司,以公司及國藥集團所屬的其他企業在醫療、醫藥物資流通環節及產業上下游的資源為切入點,打造醫療、醫藥物資流通全過程監管互聯網平台,實現國家、省、市、縣、鄉、村等各級物資線上需求對接、線上調配和配送狀態線上掌握,有效提升國家醫療醫藥應急物資保障能力。

合資公司成立後,公司及其他合作方將充分利用已有的產業上下游優勢資源,承擔國家級醫療醫藥衞生應急保障體系互聯網平台建設任務,為政府及社會提供專業優質的服務,並獲得相應收益,形成良好的商業模式。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account